A purified inactivated Japanese encephalitis virus vaccine made in vero cells

被引:81
作者
Srivastava, AK
Putnak, JR
Lee, SH
Hong, SP
Moon, SB
Barvir, DA
Zhao, BT
Olson, RA
Kim, SO
Yoo, WD
Towle, AC
Vaughn, DW
Innis, BL
Eckels, KH
机构
[1] Walter Reed Army Inst Res, Div Communible Dis & Immunol, Silver Spring, MD 20910 USA
[2] Cheil Jedang Corp, Ctr Res & Dev, Kyongg Do 467810, South Korea
[3] CJ Amer, Ridgefield Pk, NJ 07660 USA
关键词
JE-PIV; Vero cells; vaccine;
D O I
10.1016/S0264-410X(01)00208-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A second generation, purified, inactivated vaccine (PIV) against Japanese encephalitis (JE) virus was produced and tested in mice where it was found to be highly immunogenic and protective. The JE-PIV was made from an attenuated strain of JE virus propagated in certified Vero cells. purified. and inactivated with formalin. Its manufacture followed current GMP guidelines for the production of biologicals. The manufacturing process was efficient in generating a high yield of virus, essentially free of contaminating host cell proteins and nucleic acids, The PIV was formulated with aluminum hydroxide and administered to mice by subcutaneous inoculation. Vaccinated animals developed high-titered JE virus neutralizing antibodies in a dose dependant fashion after two injections. The vaccine protected mice against morbidity and mortality after challenge with live, virulent. JE virus, Compared with the existing licensed mouse brain-derived vaccine. JE-Vax. the Vero cell-derived JE-PIV was more immunogenic and as effective as preventing encephalitis in mice. The JE-PIV is currently being tested for safety and immunogenicity in volunteers. (C) 2001 Published by Elsevier Science Ltd.
引用
收藏
页码:4557 / 4565
页数:9
相关论文
共 30 条
[1]  
[Anonymous], VACCINES
[2]   Systemic reactions in US Marine Corps personnel who received Japanese encephalitis vaccine [J].
Berg, SW ;
Mitchell, BS ;
Hanson, RK ;
Olafson, RP ;
Williams, RP ;
Tueller, JE ;
Burton, RJ ;
Novak, DM ;
Tsai, TF ;
Wignall, FS .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :265-266
[3]   PRODUCTION AND CHARACTERIZATION OF ARBOVIRUS ANTIBODY IN MOUSE ASCITIC FLUID [J].
BRANDT, WE ;
BUESCHER, EL ;
HETRICK, FM .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1967, 16 (03) :339-&
[4]  
BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
[5]   FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATION [J].
CHAMBERS, TJ ;
HAHN, CS ;
GALLER, R ;
RICE, CM .
ANNUAL REVIEW OF MICROBIOLOGY, 1990, 44 :649-688
[6]   TECHNIQUES FOR HEMAGGLUTINATION AND HEMAGGLUTINATION-INHIBITION WITH ARTHROPOD-BORNE VIRUSES [J].
CLARKE, DH ;
CASALS, J .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1958, 7 (05) :561-573
[7]  
DUREUX B, 1986, LANCET, V2, P8498
[8]   JAPANESE ENCEPHALITIS-VIRUS LIVE-ATTENUATED VACCINE, CHINESE STRAIN SA14-14-2 - ADAPTATION TO PRIMARY CANINE KIDNEY-CELL CULTURES AND PREPARATION OF A VACCINE FOR HUMAN USE [J].
ECKELS, KH ;
YONGXIN, Y ;
DUBOIS, DR ;
MARCHETTE, NJ ;
TRENT, DW ;
JOHNSON, AJ .
VACCINE, 1988, 6 (06) :513-518
[9]   Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): A case-control study [J].
Hennessy, S ;
Liu, ZL ;
Tsai, TF ;
Strom, BL ;
Wan, CM ;
Liu, HL ;
Wu, TX ;
Yu, HJ ;
Liu, QM ;
Karabatsos, N ;
Bilker, WB ;
Halstead, SB .
LANCET, 1996, 347 (9015) :1583-1586
[10]   PROTECTION AGAINST JAPANESE ENCEPHALITIS BY INACTIVATED VACCINES [J].
HOKE, CH ;
NISALAK, A ;
SANGAWHIPA, N ;
JATANASEN, S ;
LAORAKAPONGSE, T ;
INNIS, BL ;
KOTCHASENEE, SO ;
GINGRICH, JB ;
LATENDRESSE, J ;
FUKAI, K ;
BURKE, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (10) :608-614